FTC files preliminary injunction against CSL/Talecris
02 June 2009
Sita Shah
Please Login to read the full article.
02 June 2009
Sita Shah
sita.shah@informa.com
The US Federal Trade Commission ( FTC) has filed a preliminary injunction to block the proposed $3.1 billion merger of CSL and Talecris Biotherapeutics.
The agency asserts that the planned merger between the world's second and third largest manufacturers of plasma products would reduce...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Halozyme, Baxter release positive PhIII results for a much-welcomed subcutaneous Gammagard Liquid
- Supreme Court rules against statistically significant 'bright-line' rule in Matrixx
- GSK disputes Argentine fine over baby vaccination scandal
- Will Shire's acute HAE drug OK shift dynamic for ViroPharma's prophylactic?
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
